AIRLINK 196.99 Increased By ▲ 5.15 (2.68%)
BOP 10.14 Increased By ▲ 0.27 (2.74%)
CNERGY 7.82 Increased By ▲ 0.15 (1.96%)
FCCL 38.10 Increased By ▲ 0.24 (0.63%)
FFL 15.99 Increased By ▲ 0.23 (1.46%)
FLYNG 25.30 Decreased By ▼ -0.01 (-0.04%)
HUBC 131.25 Increased By ▲ 1.08 (0.83%)
HUMNL 13.75 Increased By ▲ 0.16 (1.18%)
KEL 4.65 Decreased By ▼ -0.02 (-0.43%)
KOSM 6.34 Increased By ▲ 0.13 (2.09%)
MLCF 44.90 Increased By ▲ 0.61 (1.38%)
OGDC 209.15 Increased By ▲ 2.28 (1.1%)
PACE 6.67 Increased By ▲ 0.11 (1.68%)
PAEL 40.75 Increased By ▲ 0.20 (0.49%)
PIAHCLA 17.62 Increased By ▲ 0.03 (0.17%)
PIBTL 8.09 Increased By ▲ 0.02 (0.25%)
POWER 9.41 Increased By ▲ 0.17 (1.84%)
PPL 180.00 Increased By ▲ 1.44 (0.81%)
PRL 39.99 Increased By ▲ 0.91 (2.33%)
PTC 24.47 Increased By ▲ 0.33 (1.37%)
SEARL 110.42 Increased By ▲ 2.57 (2.38%)
SILK 1.00 Increased By ▲ 0.03 (3.09%)
SSGC 38.25 Decreased By ▼ -0.86 (-2.2%)
SYM 19.25 Increased By ▲ 0.13 (0.68%)
TELE 8.71 Increased By ▲ 0.11 (1.28%)
TPLP 12.13 Decreased By ▼ -0.24 (-1.94%)
TRG 65.39 Decreased By ▼ -0.62 (-0.94%)
WAVESAPP 12.48 Decreased By ▼ -0.30 (-2.35%)
WTL 1.69 Decreased By ▼ -0.01 (-0.59%)
YOUW 3.92 Decreased By ▼ -0.03 (-0.76%)
BR100 12,095 Increased By 164.4 (1.38%)
BR30 35,969 Increased By 309.2 (0.87%)
KSE100 114,903 Increased By 1696.8 (1.5%)
KSE30 36,074 Increased By 508.7 (1.43%)

LONDON: The UK government announced Wednesday it is buying millions of doses of new Covid treatment pills as the Omicron variant takes hold, while cutting the isolation period for positive cases.

The government said it has signed deals to buy 4.25 million courses of two new antiviral drugs: Pfizer's ritonavir and US rival Merck/MSD's molnupiravir, which will be available early next year.

This comes on top of government announcements in October of the procurement of several hundreds of thousands of doses, and was hailed as a "mammoth deal" by Health Secretary Sajid Javid.

Molnupiravir, sold as Lagevrio, is being used in a national trial run by the University of Oxford that people can join if they have virus symptoms.

The government said it is also being made available to those who are at high risk of severe illness, such as people with cancer.

The UK was the first country in the world to approve the pill in November this year.

Pfizer's pill, marketed as Paxlovid, has yet to be authorised anywhere in the world.

Denmark first in EU to authorise Merck Covid pill

Pfizer said Tuesday that clinical trials showed it reduced hospital admissions and deaths among at-risk people by almost 90 percent, when taken a few days after symptoms began.

The government said it will be rolled out in the same way as molnupiravir "as quickly as possible" if the UK regulator approves it.

The UK has seen a surge in infections since Omicron became the dominant variant, with 90,629 cases reported Tuesday. The country is one of the hardest hit in Europe, with a death toll of 147,433.

Prime Minister Boris Johnson has resisted calls to impose stricter virus restrictions over Christmas in England, unlike the devolved governments in other UK nations.

From Wednesday, those who have caught the virus but feel well can come out of self-isolation after seven days instead of 10, potentially allowing more to join family celebrations.

This rule only applies to people who have taken two negative lateral flow tests, NHS England said.

At the same time, UK leaders were expected to announce fresh virus measures for the post-Christmas period.

Large New Year's Eve events have already been cancelled in London and Edinburgh.

Comments

Comments are closed.